Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality? von Ignatiadis, M., Dawson, S.-J.

Volltext

ctDNA as a predictive biomarker in advanced breast cancer: Lessons from the MONALEESA studies von Agostinetto, E., Ignatiadis, M.

Volltext

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 von Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., Van den Eynden, G., Baehner, F.L., Penault-Llorca, F., Perez, E.A., Thompson, E.A., Symmans, W.F., Richardson, A.L., Brock, J., Criscitiello, C., Bailey, H., Ignatiadis, M., Floris, G., Sparano, J., Kos, Z., Nielsen, T., Rimm, D.L., Allison, K.H., Reis-Filho, J.S., Loibl, S., Sotiriou, C., Viale, G., Badve, S., Adams, S., Willard-Gallo, K., Loi, S.

Volltext

Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis von Bareche, Y., Venet, D., Ignatiadis, M., Aftimos, P., Piccart, M., Rothe, F., Sotiriou, C.

Volltext

Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer von Rothé, F., Laes, J.-F., Lambrechts, D., Smeets, D., Vincent, D., Maetens, M., Fumagalli, D., Michiels, S., Drisis, S., Moerman, C., Detiffe, J.-P., Larsimont, D., Awada, A., Piccart, M., Sotiriou, C., Ignatiadis, M.

Volltext

Optimal treatment for aromatase inhibitor-resistant metastatic breast cancer patients: lessons from the PEARL study von Agostinetto, E., Ignatiadis, M.

Volltext

Liquid biopsy accelerates precision medicine von Amato, O., Aftimos, P., Ignatiadis, M.

Volltext

CDK4/6 inhibitors as neoadjuvant treatment in breast cancer—what can we learn? von Brandão, M., Ignatiadis, M.

Volltext

Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment? von Agostinetto, E., Buisseret, L., Salgado, R., Kok, M., Ignatiadis, M.

Volltext

Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients von Lambertini, M., Goldrat, O., Ferreira, A.R., Dechene, J., Azim Jr, H.A., Desir, J., Delbaere, A., t’Kint de Roodenbeke, M.-D., de Azambuja, E., Ignatiadis, M., Demeestere, I.

Volltext

Patient-reported outcomes and genomic signatures: tools to tailor adjuvant endocrine treatment? von Brandão, M., Coens, C., Ignatiadis, M.

Volltext

Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis... von Solinas, C, Ceppi, M, Lambertini, M, Scartozzi, M, Buisseret, L, Garaud, S, Fumagalli, D, de Azambuja, E, Salgado, R, Sotiriou, C, Willard-Gallo, K, Ignatiadis, M

Volltext

St Gallen International Expert Consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists von Ignatiadis, M., Buyse, M., Sotiriou, C.

Volltext

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial von Ignatiadis, M., Litière, S., Rothe, F., Riethdorf, S., Proudhon, C., Fehm, T., Aalders, K., Forstbauer, H., Fasching, P.A., Brain, E., Vuylsteke, P., Guardiola, E., Lorenz, R., Pantel, K., Tryfonidis, K., Janni, W., Piccart, M., Sotiriou, C., Rack, B., Pierga, J.-Y.

Volltext

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting von Peeters, D J E, De Laere, B, Van den Eynden, G G, Van Laere, S J, Rothé, F, Ignatiadis, M, Sieuwerts, A M, Lambrechts, D, Rutten, A, van Dam, P A, Pauwels, P, Peeters, M, Vermeulen, P B, Dirix, L Y

Volltext

Predictive factors for cancer-associated thrombosis in a large retrospective single-center study von Haltout, J., Awada, A., Paesmans, M., Moreau, M., Klastersky, J., Machiels, G., Ignatiadis, M., Kotecki, N.

Volltext

SYNERGY: Phase I and randomized phase II trial to investigate the addition of the anti-CD73 antibody oleclumab to durvalumab, paclitaxel and carboplatin for previously untreated, l... von Maurer, C., Eiger, D., Velghe, C., Aftimos, P.G., Maetens, M., Gaye, J., Paesmans, M., Ignatiadis, M., Piccart, M., Buisseret, L.

Volltext

How I treat endocrine-dependent metastatic breast cancer von Gombos, A., Goncalves, A., Curigliano, G., Bartsch, R., Kyte, J.A., Ignatiadis, M., Awada, A.

Volltext

Liquid biopsy to test new treatment strategies in breast cancer: are we there yet? von Ignatiadis, M., Piccart, M.

Volltext

The current use and attitudes towards tumor genome sequencing in breast cancer von Gingras, I., Sonnenblick, A., de Azambuja, E., Paesmans, M., Delaloge, S., Aftimos, Philippe, Piccart, M. J., Sotiriou, C., Ignatiadis, M., Azim, H. A.

Volltext